Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients

NCT04049630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

255

Enrollment

OTHER_GOV

Sponsor class

Conditions

Onchocerciasis, Ocular
Loiasis

Interventions

DRUG: LEV 1 mg/kg
DRUG: LEV 1,5 mg/kg
DRUG: LEV 2,5 mg/kg
DRUG: Placebo

Sponsor

Programme National de Lutte contre l'Onchocercose, Republic of the Congo